Pain-Specific Benefits of Higher-Dose Neubotulinum Toxin Type A in Cervical Dystonia: A Multicenter Randomized Double-Blind Crossover Trial
Arkhom Arayawichanont, Subsai Kongsaengdao · 2026
Read Pain-Specific Benefits of Higher-Dose Neubotulinum Toxin Type A in Cervical Dystonia: A Multicenter Randomized Double-Blind Crossover Trial by Arkhom Arayawichanont, Subsai Kongsaengdao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611609.txt.
Description
Arkhom Arayawichanont and Subsai Kongsaengdao run, in 2026 work, a trial of two doses of a toxin shot for neck dystonia, a fault that twists the neck and brings much pain. The shots ease the twist, yet pain often stays. The team asked if a double dose eases pain more, without new harms.
Fifty adults took both doses in turn, in blind order, each for twelve weeks. Neck scores for twist and daily function did not split by dose. The high dose, though, eased pain by a clear margin, and home and social life scores rose more too. No grave harms showed up in either arm. The team says the pain gain is real but must be checked in a fresh trial.
Catalog record
| CREATOR | Arkhom Arayawichanont, Subsai Kongsaengdao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |